These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 11828461

  • 21. Boron-containing nucleosides as potential delivery agents for neutron capture therapy of brain tumors.
    Barth RF, Yang W, Al-Madhoun AS, Johnsamuel J, Byun Y, Chandra S, Smith DR, Tjarks W, Eriksson S.
    Cancer Res; 2004 Sep 01; 64(17):6287-95. PubMed ID: 15342417
    [Abstract] [Full Text] [Related]

  • 22. Hyaluronan as carrier of carboranes for tumor targeting in boron neutron capture therapy.
    Meo CD, Panza L, Capitani D, Mannina L, Banzato A, Rondina M, Renier D, Rosato A, Crescenzi V.
    Biomacromolecules; 2007 Feb 01; 8(2):552-9. PubMed ID: 17291079
    [Abstract] [Full Text] [Related]

  • 23. Boron neutron capture therapy of primary and metastatic brain tumors.
    Barth RF, Soloway AH.
    Mol Chem Neuropathol; 1994 Feb 01; 21(2-3):139-54. PubMed ID: 8086033
    [Abstract] [Full Text] [Related]

  • 24. Synthesis of carboranes containing an azulene framework and in vitro evaluation as boron carriers.
    Nakamura H, Sekido M, Yamamoto Y.
    J Med Chem; 1997 Aug 29; 40(18):2825-30. PubMed ID: 9288164
    [Abstract] [Full Text] [Related]

  • 25. Dodeca(carboranyl)-substituted closomers: toward unimolecular nanoparticles as delivery vehicles for BNCT.
    Thomas J, Hawthorne MF.
    Chem Commun (Camb); 2001 Sep 21; (18):1884-5. PubMed ID: 12240362
    [Abstract] [Full Text] [Related]

  • 26. Synthesis and characterization of oligomeric nido-carboranyl phosphate diester conjugates to antibody and antibody fragments for potential use in boron neutron capture therapy of solid tumors.
    Chen CJ, Kane RR, Primus FJ, Szalai G, Hawthorne MF, Shively JE.
    Bioconjug Chem; 1994 Sep 21; 5(6):557-64. PubMed ID: 7873658
    [Abstract] [Full Text] [Related]

  • 27. Carboranylporphyrins for boron neutron capture therapy of cancer.
    Evstigneeva RP, Zaitsev AV, Luzgina VN, Ol' Shevskaya VA, Shtil AA.
    Curr Med Chem Anticancer Agents; 2003 Nov 21; 3(6):383-92. PubMed ID: 14529446
    [Abstract] [Full Text] [Related]

  • 28. Intracellular uptake of a new boronated porphyrin EC032.
    Tsurubuchi T, Yamamoto T, Nakai K, Zaboronok A, Yoshida F, Miyakawa M, Shirakawa M, Yamamoto Y, Matsuda M, Matsumura A.
    Appl Radiat Isot; 2009 Jul 21; 67(7-8 Suppl):S94-6. PubMed ID: 19410469
    [Abstract] [Full Text] [Related]

  • 29. Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT).
    Thirumamagal BT, Zhao XB, Bandyopadhyaya AK, Naranyanasamy S, Johnsamuel J, Tiwari R, Golightly DW, Patel V, Jehning BT, Backer MV, Barth RF, Lee RJ, Backer JM, Tjarks W.
    Bioconjug Chem; 2006 Jul 21; 17(5):1141-50. PubMed ID: 16984121
    [Abstract] [Full Text] [Related]

  • 30. Synthesis of functionalized carboranes as potential anticancer and BNCT agents.
    Reddy VJ, Roforth MM, Tan C, Reddy MV.
    Inorg Chem; 2007 Jan 22; 46(2):381-3. PubMed ID: 17279815
    [Abstract] [Full Text] [Related]

  • 31. Treatment of isografted 9L rat brain tumors with beta-5-o-carboranyl-2'-deoxyuridine neutron capture therapy.
    Schinazi RF, Hurwitz SJ, Liberman I, Juodawlkis AS, Tharnish P, Shi J, Liotta DC, Coderre JA, Olson J.
    Clin Cancer Res; 2000 Feb 22; 6(2):725-30. PubMed ID: 10690559
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
    Hsieh CH, Chen YF, Chen FD, Hwang JJ, Chen JC, Liu RS, Kai JJ, Chang CW, Wang HE.
    J Nucl Med; 2005 Nov 22; 46(11):1858-65. PubMed ID: 16269600
    [Abstract] [Full Text] [Related]

  • 33. [Development of the method of magnetic neutron capture therapy of cancer].
    Kuznetsov AA, Podoĭnitsyn SN, Filippov VI, Komissarova LKh.
    Izv Akad Nauk Ser Biol; 2005 Nov 22; (4):448-52. PubMed ID: 16212266
    [Abstract] [Full Text] [Related]

  • 34. Synthesis and biological properties of 5-o-carboranyl-1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)uracil.
    Fulcrand-el Kattan G, Goudgaon NM, Ilksoy N, Huang JT, Watanabe KA, Sommadossi JP, Schinazi RF.
    J Med Chem; 1994 Aug 05; 37(16):2583-8. PubMed ID: 8057301
    [Abstract] [Full Text] [Related]

  • 35. Comparative in vitro evaluation of dequalinium B, a new boron carrier for neutron capture therapy (NCT).
    Adams DM, Ji W, Barth RF, Tjarks W.
    Anticancer Res; 2000 Aug 05; 20(5B):3395-402. PubMed ID: 11131639
    [Abstract] [Full Text] [Related]

  • 36. Synthesis and biological evaluation of boronated nucleosides for boron neutron capture therapy (BNCT) of cancer.
    Tjarks W, Wang J, Chandra S, Ji W, Zhuo J, Lunato AJ, Boyer C, Li Q, Usova EV, Eriksson S, Morrison GH, Cosquer GY.
    Nucleosides Nucleotides Nucleic Acids; 2001 Aug 05; 20(4-7):695-8. PubMed ID: 11563094
    [Abstract] [Full Text] [Related]

  • 37. Synthesis, Molecular Docking, and In Vitro Boron Neutron Capture Therapy Assay of Carboranyl Sinomenine.
    Cai J, Hosmane NS, Takagaki M, Zhu Y.
    Molecules; 2020 Oct 14; 25(20):. PubMed ID: 33066470
    [Abstract] [Full Text] [Related]

  • 38. Strategy for boron neutron capture therapy against tumor cells with over-expression of the epidermal growth factor-receptor.
    Carlsson J, Gedda L, Grönvik C, Hartman T, Lindström A, Lindström P, Lundqvist H, Lövqvist A, Malmqvist J, Olsson P.
    Int J Radiat Oncol Biol Phys; 1994 Aug 30; 30(1):105-15. PubMed ID: 7521866
    [Abstract] [Full Text] [Related]

  • 39. Introductory experiments on ligand liposomes as delivery agents for boron neutron capture therapy.
    Bohl Kullberg E, Carlsson J, Edwards K, Capala J, Sjöberg S, Gedda L.
    Int J Oncol; 2003 Aug 30; 23(2):461-7. PubMed ID: 12851696
    [Abstract] [Full Text] [Related]

  • 40. 3-Carboranyl thymidine analogues (3CTAs) and other boronated nucleosides for boron neutron capture therapy.
    Byun Y, Narayanasamy S, Johnsamuel J, Bandyopadhyaya AK, Tiwari R, Al-Madhoun AS, Barth RF, Eriksson S, Tjarks W.
    Anticancer Agents Med Chem; 2006 Mar 30; 6(2):127-44. PubMed ID: 16529536
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.